Distribution of FK 506 in plasma lipoproteins in transplant patients.
作者信息
Warty V, Venkataramanan R, Zendehrouh P, McKaveney T, Chao J, Todo S, Starzl T
机构信息
Department of Pathology, University of Pittsburgh, Pennsylvania 15213.
出版信息
Transplant Proc. 1991 Feb;23(1 Pt 2):954-5.
Abstract
摘要
相似文献
1
Distribution of FK 506 in plasma lipoproteins in transplant patients.移植患者血浆脂蛋白中FK 506的分布
Transplant Proc. 1991 Feb;23(1 Pt 2):954-5.
2
Bioassay of plasma specimens from liver transplant patients on FK 506 immunosuppression.对接受FK 506免疫抑制治疗的肝移植患者血浆样本进行生物测定。
Transplant Proc. 1990 Feb;22(1):60-3.
3
4
Glucose and lipid metabolism in liver transplant patients under long-term tacrolimus (FK 506) monotherapy.长期接受他克莫司（FK 506）单药治疗的肝移植患者的糖脂代谢
Transplant Proc. 1996 Apr;28(2):1006-7.
5
Assay of FK 506 in plasma.血浆中FK 506的测定
Transplant Proc. 1990 Feb;22(1):50-1.
6
Lymphoproliferative disorders arising under immunosuppression with FK 506: initial observations in a large transplant population.在使用FK 506免疫抑制情况下出现的淋巴增生性疾病：对一大群移植受者的初步观察
Transplant Proc. 1991 Feb;23(1 Pt 2):1108-10.
7
FK 506: an immunosuppressant for the 1990s?FK506：20世纪90年代的一种免疫抑制剂？
Lancet. 1991 Jan 5;337(8732):25-7. doi: 10.1016/0140-6736(91)93341-6.
8
Lipoprotein patterns in renal transplant patients: a comparison between FK 506 and cyclosporine A patients.
Transplant Proc. 1998 Jun;30(4):1292-4. doi: 10.1016/s0041-1345(98)00246-2.
9
FK 506.他克莫司
Lancet. 1991 Feb 23;337(8739):499. doi: 10.1016/0140-6736(91)93441-b.
10
Tacrolimus (FK 506) in kidney transplantation: three-year survival results of the US multicenter, randomized, comparative trial. FK 506 Kidney Transplant Study Group.他克莫司（FK506）在肾移植中的应用：美国多中心随机对照试验的三年生存结果。FK506肾移植研究组
Transplant Proc. 1998 Jun;30(4):1216-8. doi: 10.1016/s0041-1345(98)00216-4.
引用本文的文献
1
Factors affecting variability in distribution of tacrolimus in liver transplant recipients.影响肝移植受者他克莫司分布变异性的因素。
Br J Clin Pharmacol. 2004 Mar;57(3):298-309. doi: 10.1046/j.1365-2125.2003.02008.x.
2
Clinical pharmacokinetics of tacrolimus.他克莫司的临床药代动力学
Clin Pharmacokinet. 1995 Dec;29(6):404-30. doi: 10.2165/00003088-199529060-00003.
3
Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.他克莫司。其药理学及在肝移植和肾移植中的治疗潜力综述。
Drugs. 1993 Oct;46(4):746-94. doi: 10.2165/00003495-199346040-00009.
4
In vitro assessment of FK 506 immunosuppressive activity in transplant patients.移植患者中FK 506免疫抑制活性的体外评估。
Transplant Proc. 1991 Dec;23(6):2897-9.
5
Pharmacokinetics of FK 506 in transplant patients.FK506在移植患者中的药代动力学。
Transplant Proc. 1991 Dec;23(6):2736-40.
6
Pharmacokinetics of FK 506 following oral administration: a comparison of FK 506 and cyclosporine.口服给药后FK 506的药代动力学：FK 506与环孢素的比较。
Transplant Proc. 1991 Feb;23(1 Pt 2):931-3.
本文引用的文献
1
The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.人血清中超离心分离的脂蛋白的分布及化学组成
J Clin Invest. 1955 Sep;34(9):1345-53. doi: 10.1172/JCI103182.
2
The transport of cyclosporine in association with plasma lipoproteins in heart and liver transplant patients.心脏和肝脏移植患者中环孢素与血浆脂蛋白的转运。
Transplant Proc. 1985 Aug;17(4):1997-2002.
3
Action and toxicity of cyclosporine.环孢素的作用与毒性。
Annu Rev Med. 1986;37:215-24. doi: 10.1146/annurev.me.37.020186.001243.
4
A highly sensitive method to assay FK-506 levels in plasma.一种检测血浆中FK-506水平的高灵敏度方法。
Transplant Proc. 1987 Oct;19(5 Suppl 6):23-9.
5
Bioassay of plasma specimens from liver transplant patients on FK 506 immunosuppression.对接受FK 506免疫抑制治疗的肝移植患者血浆样本进行生物测定。
Transplant Proc. 1990 Feb;22(1):60-3.
6
Effect of hepatic dysfunction and T tube clamping on FK 506 pharmacokinetics and trough concentrations.肝功能不全和T管夹闭对FK 506药代动力学及谷浓度的影响。
Transplant Proc. 1990 Feb;22(1):57-9.
Zotero 插件